Published in Am J Psychiatry on May 01, 2011
Psychiatric diagnosis revisited: towards a system of staging and profiling combining nomothetic and idiographic parameters of momentary mental states. PLoS One (2013) 1.31
At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk. Schizophr Bull (2012) 1.24
Attenuated psychosis syndrome in DSM-5. Schizophr Res (2013) 1.24
Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study. Schizophr Bull (2011) 1.17
Whither the attenuated psychosis syndrome? Schizophr Bull (2012) 1.12
The validity of the 16-item version of the Prodromal Questionnaire (PQ-16) to screen for ultra high risk of developing psychosis in the general help-seeking population. Schizophr Bull (2012) 1.05
DSM-5 status of psychotic disorders: 1 year prepublication. Schizophr Bull (2012) 1.01
Prevalence of attenuated psychotic symptoms and their relationship with DSM-IV diagnoses in a general psychiatric outpatient clinic. J Clin Psychiatry (2012) 1.00
Psychotic Experiences in the General Population: A Cross-National Analysis Based on 31,261 Respondents From 18 Countries. JAMA Psychiatry (2015) 1.00
Glycine treatment of the risk syndrome for psychosis: report of two pilot studies. Eur Neuropsychopharmacol (2012) 0.97
Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011. Schizophr Res (2013) 0.90
Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention. Neuropsychiatry (London) (2012) 0.86
Status of psychotic disorders in ICD-11. Schizophr Bull (2012) 0.86
At issue: Cochrane, early intervention, and mental health reform: analysis, paralysis, or evidence-informed progress? Schizophr Bull (2012) 0.84
Psychosis prediction and clinical utility in familial high-risk studies: selective review, synthesis, and implications for early detection and intervention. Early Interv Psychiatry (2013) 0.81
Is pharmacological intervention necessary in prodromal schizophrenia? Shanghai Arch Psychiatry (2012) 0.79
Interpersonal sensitivity and functioning impairment in youth at ultra-high risk for psychosis. Eur Child Adolesc Psychiatry (2015) 0.77
Social cognition as an RDoC domain. Am J Med Genet B Neuropsychiatr Genet (2015) 0.76
The prodrome and clinical risk for psychotic disorders. Child Adolesc Psychiatr Clin N Am (2013) 0.76
The field of schizophrenia: strengths, weaknesses, opportunities, and threats. Schizophr Bull (2011) 0.76
Field testing attenuated psychosis syndrome criteria. Am J Psychiatry (2011) 0.75
Values and DSM-5: looking at the debate on attenuated psychosis syndrome. BMC Med Ethics (2016) 0.75
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry (2005) 6.27
The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull (2006) 5.59
Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 4.63
Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ (2011) 3.84
The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci Biobehav Rev (2010) 3.77
Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr Bull (2012) 3.46
"Schizophrenia" does not exist. BMJ (2016) 3.34
Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ (2004) 2.93
The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. Am J Psychiatry (2007) 2.89
Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophr Bull (2008) 2.59
Cannabis use and vulnerability for psychosis in early adolescence--a TRAILS study. Addiction (2013) 2.46
Ethnic density of neighborhoods and incidence of psychotic disorders among immigrants. Am J Psychiatry (2007) 2.45
Evidence that early extrapyramidal symptoms predict later tardive dyskinesia: a prospective analysis of 10,000 patients in the European Schizophrenia Outpatient Health Outcomes (SOHO) study. Am J Psychiatry (2006) 2.44
A salience dysregulation syndrome. Br J Psychiatry (2009) 2.23
The effects of FreeSurfer version, workstation type, and Macintosh operating system version on anatomical volume and cortical thickness measurements. PLoS One (2012) 2.18
Early expression of negative/disorganized symptoms predicting psychotic experiences and subsequent clinical psychosis: a 10-year study. Am J Psychiatry (2010) 2.10
Does the urban environment cause psychosis? Br J Psychiatry (2004) 2.10
The incidence and outcome of subclinical psychotic experiences in the general population. Br J Clin Psychol (2005) 2.00
Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol (2005) 1.96
Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophr Bull (2009) 1.93
The environment and schizophrenia: the role of cannabis use. Schizophr Bull (2005) 1.90
Schizophrenia and urbanicity: a major environmental influence--conditional on genetic risk. Schizophr Bull (2005) 1.88
Children's health-related quality of life, neighbourhood socio-economic deprivation and social capital. A contextual analysis. Soc Sci Med (2003) 1.86
Psychosis reactivity to cannabis use in daily life: an experience sampling study. Br J Psychiatry (2010) 1.81
Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophr Res (2002) 1.80
Stress-reactivity in psychosis: evidence for an affective pathway to psychosis. Clin Psychol Rev (2007) 1.78
Psychotic experiences in the general population: a twenty-year prospective community study. Schizophr Res (2007) 1.77
Cannabis use and expression of mania in the general population. J Affect Disord (2006) 1.76
Prediction of transition from common adolescent bipolar experiences to bipolar disorder: 10-year study. Br J Psychiatry (2010) 1.75
Stress-related negative affectivity and genetically altered serotonin transporter function: evidence of synergism in shaping risk of depression. Arch Gen Psychiatry (2006) 1.74
Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry (2008) 1.70
Efficacy of mindfulness-based cognitive therapy in relation to prior history of depression: randomised controlled trial. Br J Psychiatry (2012) 1.70
Childhood trauma as a cause of psychosis: linking genes, psychology, and biology. Can J Psychiatry (2013) 1.66
Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. Schizophr Res (2005) 1.64
Childhood trauma and emotional reactivity to daily life stress in adult frequent attenders of general practitioners. J Psychosom Res (2006) 1.63
Maintaining informed consent validity during lengthy research protocols. IRB (2008) 1.62
Pediatric illness severity measures predict delirium in a pediatric intensive care unit. Crit Care Med (2008) 1.60
Psychopathological mechanisms linking childhood traumatic experiences to risk of psychotic symptoms: analysis of a large, representative population-based sample. Schizophr Bull (2014) 1.59
Olanzapine treatment of residual positive and negative symptoms. Am J Psychiatry (2005) 1.57
Pediatric delirium in critical illness: phenomenology, clinical correlates and treatment response in 40 cases in the pediatric intensive care unit. Intensive Care Med (2007) 1.57
The BDNF Val(66)Met x 5-HTTLPR x child adversity interaction and depressive symptoms: An attempt at replication. Am J Med Genet B Neuropsychiatr Genet (2008) 1.55
Time for a shift in focus in schizophrenia: from narrow phenotypes to broad endophenotypes. Br J Psychiatry (2005) 1.55
Determinants of occurrence and recovery from hallucinations in daily life. Soc Psychiatry Psychiatr Epidemiol (2002) 1.53
Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. Neuropsychopharmacology (2006) 1.53
The epigenome and postnatal environmental influences in psychotic disorders. Soc Psychiatry Psychiatr Epidemiol (2014) 1.51
Effectively working on rehabilitation goals: 24-month outcome of a randomized controlled trial of the Boston psychiatric rehabilitation approach. Can J Psychiatry (2011) 1.51
Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity--implications for diagnosis and ultra-high risk research. Schizophr Bull (2012) 1.50
Will the Kraepelinian dichotomy survive DSM-V? Neuropsychopharmacology (2009) 1.47
Systematic reviews of categorical versus continuum models in psychosis: evidence for discontinuous subpopulations underlying a psychometric continuum. Implications for DSM-V, DSM-VI, and DSM-VII. Annu Rev Clin Psychol (2010) 1.44
Catatonia in DSM-5. Schizophr Res (2013) 1.43
Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England. Am J Psychiatry (2005) 1.42
Impact of psychological trauma on the development of psychotic symptoms: relationship with psychosis proneness. Br J Psychiatry (2006) 1.40
Jaspers was right after all--delusions are distinct from normal beliefs. Against. Br J Psychiatry (2003) 1.40
Managing complex patients on a medical psychiatric unit: an observational study of university hospital costs associated with medical service use, length of stay, and psychiatric intervention. J Psychosom Res (2009) 1.40
Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale. Schizophr Res (2012) 1.37
Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability? Brain Behav Immun (2010) 1.36
Treatment of schizophrenia negative symptoms: future prospects. Schizophr Bull (2006) 1.35
Self-reported attenuated psychotic symptoms as forerunners of severe mental disorders later in life. Arch Gen Psychiatry (2012) 1.35
Epigenetic regulation in the pathophysiology of Alzheimer's disease. Prog Neurobiol (2010) 1.34
A therapeutic application of the experience sampling method in the treatment of depression: a randomized controlled trial. World Psychiatry (2014) 1.33
Affective dysregulation and reality distortion: a 10-year prospective study of their association and clinical relevance. Schizophr Bull (2009) 1.32
Reduced cortical thickness as an outcome of differential sensitivity to environmental risks in schizophrenia. Biol Psychiatry (2010) 1.32
Emotions, self-esteem, and paranoid episodes: an experience sampling study. Br J Clin Psychol (2011) 1.32
Psychiatric diagnosis revisited: towards a system of staging and profiling combining nomothetic and idiographic parameters of momentary mental states. PLoS One (2013) 1.31
Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Schizophr Bull (2006) 1.30
Childhood trauma and psychosis: a case-control and case-sibling comparison across different levels of genetic liability, psychopathology, and type of trauma. Am J Psychiatry (2011) 1.30
An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology (2006) 1.29
A time-lagged momentary assessment study on daily life physical activity and affect. Health Psychol (2011) 1.29
Anticipating DSM-V: should psychosis risk become a diagnostic class? Schizophr Bull (2009) 1.27
Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines. Schizophr Res (2010) 1.26
At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk. Schizophr Bull (2012) 1.24
Data gathering: biased in psychosis? Schizophr Bull (2005) 1.24
Effect of COMT Val158Met polymorphism on the Continuous Performance Test, Identical Pairs Version: tuning rather than improving performance. Am J Psychiatry (2005) 1.23
Childhood victimisation and developmental expression of non-clinical delusional ideation and hallucinatory experiences: victimisation and non-clinical psychotic experiences. Soc Psychiatry Psychiatr Epidemiol (2006) 1.23
Mindfulness training increases momentary positive emotions and reward experience in adults vulnerable to depression: a randomized controlled trial. J Consult Clin Psychol (2011) 1.23
Factor structure of the Brief Negative Symptom Scale. Schizophr Res (2012) 1.23
Evidence that moment-to-moment variation in positive emotions buffer genetic risk for depression: a momentary assessment twin study. Acta Psychiatr Scand (2007) 1.22
Refractory agitation as a marker for pediatric delirium in very young infants at a pediatric intensive care unit. Intensive Care Med (2010) 1.22
The structure of the extended psychosis phenotype in early adolescence--a cross-sample replication. Schizophr Bull (2009) 1.21
On the utility of diagnostic instruments for pediatric delirium in critical illness: an evaluation of the Pediatric Anesthesia Emergence Delirium Scale, the Delirium Rating Scale 88, and the Delirium Rating Scale-Revised R-98. Intensive Care Med (2011) 1.20
Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia. Schizophr Res (2006) 1.19
Remission criteria for schizophrenia: evaluation in a large naturalistic cohort. Schizophr Res (2007) 1.19
Evidence that onset of psychosis in the population reflects early hallucinatory experiences that through environmental risks and affective dysregulation become complicated by delusions. Schizophr Bull (2010) 1.18
An observational, "real life" trial of the introduction of assertive community treatment in a geographically defined area using clinical rather than service use outcome criteria. Soc Psychiatry Psychiatr Epidemiol (2007) 1.18
A real-life observational study of the effectiveness of FACT in a Dutch mental health region. BMC Psychiatry (2008) 1.17
Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. J Psychiatr Res (2013) 1.16
Rumination and worrying as possible mediators in the relation between neuroticism and symptoms of depression and anxiety in clinically depressed individuals. Behav Res Ther (2008) 1.15
Emotional experience in negative symptoms of schizophrenia--no evidence for a generalized hedonic deficit. Schizophr Bull (2011) 1.15
Children's mental health service use, neighbourhood socioeconomic deprivation, and social capital. Soc Psychiatry Psychiatr Epidemiol (2003) 1.15
Fluctuations in self-esteem and paranoia in the context of daily life. J Abnorm Psychol (2008) 1.14
Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations. Psychol Bull (2009) 1.14
Phenotypically continuous with clinical psychosis, discontinuous in need for care: evidence for an extended psychosis phenotype. Schizophr Bull (2011) 1.14
Transition from stress sensitivity to a depressive state: longitudinal twin study. Br J Psychiatry (2009) 1.13
The catechol-O-methyl transferase Val158Met polymorphism and experience of reward in the flow of daily life. Neuropsychopharmacology (2007) 1.12
Association between short birth intervals and schizophrenia in the offspring. Schizophr Res (2004) 1.12
Another view of therapy for cognition in schizophrenia. Biol Psychiatry (2002) 1.11
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10